Annexin A2 Causes Motor Incoordination via Muscle–Cerebellum Axis in Sarcopenia
ANXA2 is a key mediator of the muscle-cerebellum axis in sarcopenia, contributing to muscle atrophy by downregulating Neu2 and motor incoordination by targeting CB2R. Isoliquiritigenin was identified as an effective compound targeting ANXA2 to improve motor deficits. These findings highlight ANXA2 as a potential therapeutic target and suggest isoliquiritigenin as a promising strategy for alleviating motor incoordination associated with sarcopenia.
Authors
- Chen Xu
- Xinfa Shao
- Xinlin Jia
- Hanwen Chang
- Yuxin Zhang
- Dongyun Gu
- Zengguang Wang
- Binbin Wang
- Dinghao Luo
- Xingzuan Lin
- Yixuan Lin
- Xianhao Zhou
- Tanjun Deng
- Yongjin Li
- Xin Jiao
- Yaokai Gan
- Wentao Li
Institutions
- Shenzhen University (CN)
- Shanghai Jiao Tong University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Shanghai Ninth People's Hospital (CN)
- Peking University Third Hospital (CN)
Publication Details
- Journal
- Journal of Cachexia Sarcopenia and Muscle
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1002/jcsm.70203
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 0.00